Facial filler trial aims to reverse 'Ozempic Face'
NCT ID NCT07419854
First seen Feb 24, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This study tests whether a dermal filler called Radiesse (CaHA) can restore lost facial volume and improve skin quality in people who have lost weight using GLP-1 drugs like Ozempic. About 48 adults starting GLP-1 therapy will be randomly assigned to receive the filler either right away or after 6 months. Researchers will use 3D imaging to measure changes in cheek volume, jowl volume, and facial lines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VOLUME LOSS (SOFT TISSUE PTOSIS OR ATROPHY ) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
K. Kay Durairaj, MD, A Medical Corp.
RECRUITINGPasadena, California, 91105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.